Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Epidemiological studies consistently show that circulating sex hormone binding globulin (SHBG) levels are lower in type 2 diabetes patients than non-diabetic individuals, but the causal nature of this association is controversial. Genetic studies can help dissect causal directions of epidemiological associations because genotypes are much less likely to be confounded, biased or influenced by disease processes. Using this Mendelian randomization principle, we selected a common single nucleotide polymorphism (SNP) near the SHBG gene, rs1799941, that is strongly associated with SHBG levels. We used data from this SNP, or closely correlated SNPs, in 27 657 type 2 diabetes patients and 58 481 controls from 15 studies. We then used data from additional studies to estimate the difference in SHBG levels between type 2 diabetes patients and controls. The SHBG SNP rs1799941 was associated with type 2 diabetes [odds ratio (OR) 0.94, 95% CI: 0.91, 0.97; P = 2 x 10(-5)], with the SHBG raising allele associated with reduced risk of type 2 diabetes. This effect was very similar to that expected (OR 0.92, 95% CI: 0.88, 0.96), given the SHBG-SNP versus SHBG levels association (SHBG levels are 0.2 standard deviations higher per copy of the A allele) and the SHBG levels versus type 2 diabetes association (SHBG levels are 0.23 standard deviations lower in type 2 diabetic patients compared to controls). Results were very similar in men and women. There was no evidence that this variant is associated with diabetes-related intermediate traits, including several measures of insulin secretion and resistance. Our results, together with those from another recent genetic study, strengthen evidence that SHBG and sex hormones are involved in the aetiology of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“higher levels associated with reduced risk of type 2 diabetes [63], [64].”
From Impact of Five Nights of Sleep Restriction on Glucose Metabolism, Leptin and Testosterone in Young Adult Men (2012) · cites this paper as [64]
The cited source says what the claim attributes to it.
In the citing paper
“Particular single nucleotide polymorphisms (SNPs) for SHBG confer increased risk for T2D (102, 104).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882 · cited 1×
“Genetic studies can be a valuable additional tool which help to dissect causal directions of epidemiological associations (14).”
BackgroundVariant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287 · cited 1×
“39, are similar to those for SNPs in the TCF7L2 gene (9), which raises doubt as to why these associations were not found by genome-wide association approaches, and the evidence of association between SHBG SNPs and type 2 diabetes was not strong (P 1⁄4 0.”
BackgroundWellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864 · cited 1×
“12], all of European ancestry] (22), and this SNP appears to be less strongly associated with SHBG levels than rs1799941, based on data from previous studies (23,24).”
BackgroundSelf-citationDing, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
NILSSEN, O., FØRDE, O. H., & BRENN, T. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115661 · Cited by 815
Variants in MTNR1B influence fasting glucose levels
Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Thorleifsson, G., Loos, R. J. F., Manning, A. K., Jackson, A. U., Aulchenko, Y., et al. (2009) · Nature Genetics · doi:10.1038/ng.290 · Cited by 744 · cited 1×
“For measures of fasting glucose and homeostatic model assessment (HOMA) based measures of insulin resistance, we used data from MAGIC of between 36 135 and 45 691 individuals, details of which are described in detail elsewhere (31).”
Self-citationSex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726 · cited 3×
“02 for each SNP under the best model) (2).”
BackgroundInfluentialGudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2062 · Cited by 723 · cited 1×
“Second, a SNP (rs6259) in the SHBG gene has been associated with prostate cancer and there is increasing evidence that there may be a casual link to the inverse association between prostate cancer and type 2 diabetes (27), although our results suggest that this requires additional studies of rs1799941 in prostate canc…”
ResultSelf-citationPasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635 · cited 1×
“Finally, insulin lowering interventions in non-diabetic men and women (without PCOS) lead to increased SHBG levels, suggesting that insulin can causally influence sex hormone dynamics (12,13).”
BackgroundThe effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin, P., Holmäng, S., Jönsson, L., Sjöström, L., Kvist, H., Holm, G., Lindstedt, G., & Björntorp, P. A. (1992) · PubMed · Cited by 553
Cited by
The role of estrogens in control of energy balance and glucose homeostasis
Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1055 · Cited by 1,329
Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
Self-citationHepatokines: Linking nonalcoholic fatty liver disease and insulin resistance
Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631
Understanding weight gain at menopause
Davis, S. R., Castelo-Branco, C., Chedraui, P., Lumsden, M. A., Nappi, R. E., Shah, D., Villaseca, P., & as the Writing Group of the International Menopause Society for World Menopause Day 2012 (2012) · Climacteric · doi:10.3109/13697137.2012.707385 · Cited by 604
Mendelian randomization studies: a review of the approaches used and the quality of reporting
Boef, A. G. C., Dekkers, O. M., & le Cessie, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv071 · Cited by 610
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500
Low Testosterone in Men with Type 2 Diabetes: Significance and Treatment
Grossmann, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0118 · Cited by 350
Novel insights in SHBG regulation and clinical implications
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C., & Selva, D. M. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.001 · Cited by 335
Brand, J. S., van der Tweel, I., Grobbee, D. E., Emmelot-Vonk, M. H., & van der Schouw, Y. T. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq158 · Cited by 334
Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Dandona, P., & Dhindsa, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2724 · Cited by 313
The role of hepatokines in NAFLD
Stefan, N., Schick, F., Birkenfeld, A. L., Häring, H.-U., & White, M. F. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.006 · Cited by 282
Perry, J. R. B., Voight, B. F., Yengo, L., Amin, N., Dupuis, J., Ganser, M., Grallert, H., Navarro, P., Li, M., Qi, L., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002741 · Cited by 263
“These studies have highlighted new candidate pathways involved in the disease [8,9], identified overlap with monogenic forms of the disease [1], and provided genetic links with correlated phenotypes [10,11].”
BackgroundSelf-citationBudu-Aggrey, A., Brumpton, B., Tyrrell, J., Watkins, S., Modalsli, E. H., Celis-Morales, C., Ferguson, L. D., Vie, G. Å., Palmer, T., Fritsche, L. G., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002739 · Cited by 253
Self-citationCoviello, A. D., Haring, R., Wellons, M., Vaidya, D., Lehtimäki, T., Keildson, S., Lunetta, K. L., He, C., Fornage, M., Lagou, V., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002805 · Cited by 250
“3-BAIAP2L1 [alias insulin receptor tyrosine kinase substrate ( IRTKS )] are involved in susceptibility to T2D [48] and insulin signaling [47], respectively.”
InfluentialSelf-citationReynolds, A. C., Dorrian, J., Liu, P. Y., Van Dongen, H. P. A., Wittert, G. A., Harmer, L. J., & Banks, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041218 · Cited by 231
“This is particularly relevant to the relationship between sleep restriction and glucose metabolism, as low levels of endogenous SHBG have been linked with poor glucose tolerance [62,63], and conversely, higher levels associated with reduced risk of type 2 diabetes [63,64].”
BackgroundPolycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke
Zhu, T., Cui, J., & Goodarzi, M. O. (2021) · Diabetes · doi:10.2337/db20-0800 · Cited by 226
“Numerous epidemiologic and MR studies have associated lower SHBG with higher risk of diabetes in women and men, strongly suggesting a causal relationship (24,36,37).”
BackgroundGenetic determinants of serum testosterone concentrations in men
Ohlsson, C., Wallaschofski, H., Lunetta, K. L., Stolk, L., Perry, J. R. B., Koster, A., Petersen, A.-K., Eriksson, J., Lehtimäki, T., Huhtaniemi, I. T., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002313 · Cited by 224
Self-citationSex hormone binding globulin and insulin resistance
Wallace, I. R., McKinley, M. C., Bell, P. M., & Hunter, S. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12086 · Cited by 268
Brand, J. S., Rovers, M. M., Yeap, B. B., Schneider, H. J., Tuomainen, T.-P., Haring, R., Corona, G., Onat, A., Maggio, M., Bouchard, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100409 · Cited by 212
“Polymorphisms in the SHBG gene have been associated with risk of type 2 diabetes, suggesting a causal role for SHBG in metabolic disease risk [52,53].”
BackgroundSelf-citationSex hormone-binding globulin and type 2 diabetes mellitus
Le, T. N., Nestler, J. E., Strauss, J. F., & Wickham, E. P. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.09.005 · Cited by 191
“In addition to hormonal and metabolic factors, plasma SHBG levels are also affected by genetic heterogeneity [21–23], and recent findings demonstrate inheriting single nucleotide polymorphisms (SNPs) in the SHBG gene confer risk for the development of T2DM [24,25].”
BackgroundInfluentialSaboor Aftab, S. A., Kumar, S., & Barber, T. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12092 · Cited by 157
Genetics of the polycystic ovary syndrome
Kosova, G., & Urbanek, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.009 · Cited by 156
Relationships of Circulating Sex Hormone–Binding Globulin With Metabolic Traits in Humans
Peter, A., Kantartzis, K., Machann, J., Schick, F., Staiger, H., Machicao, F., Schleicher, E., Fritsche, A., Häring, H.-U., & Stefan, N. (2010) · Diabetes · doi:10.2337/db10-0179 · Cited by 154
“Recently, two studies applying the Mendelian randomization approach, an elegant tool to study causal relationships between plasma parameters and traits in humans (1), suggested that circulating sex hormone–binding globulin (SHBG) may be involved in the pathogenesis of type 2 diabetes in men and women (2,3).”
BackgroundMethodInfluentialMuka, T., Nano, J., Jaspers, L., Meun, C., Bramer, W. M., Hofman, A., Dehghan, A., Kavousi, M., Laven, J. S. E., & Franco, O. H. (2017) · Diabetes · doi:10.2337/db16-0473 · Cited by 140
Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization
Zhu, T., & Goodarzi, M. O. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab757 · Cited by 126
Ruth, K. S., Campbell, P. J., Chew, S., Lim, E. M., Hadlow, N., Stuckey, B. G., Brown, S. J., Feenstra, B., Joseph, J., Surdulescu, G. L., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.102 · Cited by 121
Self-citationBhasin, S., Jasjua, G. K., Pencina, M., D’Agostino, R., Coviello, A. D., Vasan, R. S., & Travison, T. G. (2011) · Diabetes Care · doi:10.2337/dc11-0888 · Cited by 120
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
Sanches, J. M., Zhao, L. N., Salehi, A. A., Wollheim, C. B., & Kaldis, P. (2021) · FEBS Journal · doi:10.1111/febs.16306 · Cited by 151
Hypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?
Cook, J. R., & Semple, R. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2286 · Cited by 136
Evolving utility of sex hormone-binding globulin measurements in clinical medicine
Hammond, G. L., Wu, T.-S., & Simard, M. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328353732f · Cited by 104
Wang, Q., Kangas, A. J., Soininen, P., Tiainen, M., Tynkkynen, T., Puukka, K., Ruokonen, A., Viikari, J., Kahonen, M., Lehtimaki, T., et al. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv093 · Cited by 102
“The causal effect estimates were further meta-analysed with prior studies on the causal role of SHBG.(3,4)”
MethodResultInfluentialSelf-citationChaudhary, H., Patel, J. K., Jain, N. K., & Joshi, R. G. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00879-w · Cited by 121
Association of puberty timing with type 2 diabetes: A systematic review and meta-analysis
Cheng, T. S., Day, F. R., Lakshman, R., & Ong, K. K. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003017 · Cited by 137
Steroids and insulin resistance in pregnancy
Vejražková, D., Včelák, J., Vaňková, M., Lukášová, P., Bradnová, O., Hálková, T., Kancheva, R. L., & Bendlová, B. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.11.007 · Cited by 111
Cohort Profile: Genetics of Diabetes Audit and Research in Tayside Scotland (GoDARTS)
Hébert, H. L., Shepherd, B., Milburn, K., Veluchamy, A., Meng, W., Carr, F., Donnelly, L. A., Tavendale, R., Leese, G., Colhoun, H. M., et al. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx140 · Cited by 94
Self-citationKim, H., Westerman, K. E., Smith, K., Chiou, J., Cole, J. B., Majarian, T. D., von Grotthuss, M., Kwak, S. H., Kim, J., Mercader, J. M., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05848-6 · Cited by 103
“For the SHBG cluster (seen for type 2 diabetes), our results point to a genetic pathway whereby alteration of the SHBG locus leads to reduced SHBG levels and increased type 2 diabetes risk, which was consistent with previous epidemiological and genetic studies indicating that low circulating levels of SHBG were causal…”
ResultXie, W., Wood, A. R., Lyssenko, V., Weedon, M. N., Knowles, J. W., Alkayyali, S., Assimes, T. L., Quertermous, T., Abbasi, F., Paananen, J., et al. (2013) · Diabetes · doi:10.2337/db12-0876 · Cited by 83
Self-citationSex hormone–binding globulin: biomarker and hepatokine?
Simons, P. I. H. G., Valkenburg, O., Stehouwer, C. D. A., & Brouwers, M. C. G. J. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.05.002 · Cited by 90
Sex Hormone-Binding Globulin Gene Expression and Insulin Resistance
Winters, S. J., Gogineni, J., Karegar, M., Scoggins, C., Wunderlich, C. A., Baumgartner, R., & Ghooray, D. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2640 · Cited by 79
How much does obesity affect the male reproductive function?
Bellastella, G., Menafra, D., Puliani, G., Colao, A., & Savastano, S. (2019) · International Journal of Obesity Supplements · doi:10.1038/s41367-019-0008-2 · Cited by 90
New type 2 diabetes risk genes provide new insights in insulin secretion mechanisms
Schäfer, S., Machicao, F. E., Fritsche, A., Häring, H., & Kantartzis, K. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70008-0 · Cited by 96
“ately linked rs6257, possibly also rs62569) to be associated with circulating SHBG levels and T2DM risk [51,52].”
BackgroundInfluentialGoto, A., Song, Y., Chen, B. H., Manson, J. E., Buring, J. E., & Liu, S. (2011) · Diabetes · doi:10.2337/db10-1193 · Cited by 78
“We first reported that lower levels of SHBG may be causally associated with type 2 diabetes risk using Mendelian randomization analyses (10), findings of which have been replicated by a large consortium of case-control studies (22).”
BackgroundUsefulness of Mendelian Randomization in Observational Epidemiology
Bochud, M., & Rousson, V. (2010) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph7030711 · Cited by 76
SHBG, Sex Hormones, and Inflammatory Markers in Older Women
Maggio, M., Ceda, G. P., Lauretani, F., Bandinelli, S., Corsi, A. M., Giallauria, F., Guralnik, J. M., Zuliani, G., Cattabiani, C., Parrino, S., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1902 · Cited by 77
Self-citationWood, A. R., Perry, J. R. B., Tanaka, T., Hernandez, D. G., Zheng, H.-F., Melzer, D., Gibbs, J. R., Nalls, M. A., Weedon, M. N., Spector, T. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064343 · Cited by 75
“Genetic variants can be used to help identify causal pathways using Mendelian randomisation [9–12].”
BackgroundSelf-citationChan, M. S., Arnold, M., Offer, A. R., Hammami, I., Mafham, M. M., Armitage, J., Perera, R., & Parish, S. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab069 · Cited by 79
Sex Hormone-Binding Globulin in Children and Adolescents
Aydın, B. K., & Winters, S. J. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.2764 · Cited by 82
“It has been suggested that SHBG may have a causal role in the risk of T2DM since Mendelian randomization studies have reported that carrying specific SHBG single-nucleotide polymorphisms (SNPs) affects the risk of T2DM (19,66).”
BackgroundInfluentialLiu, S., & Sun, Q. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12517 · Cited by 64
“Similar sex divergent effects were also observed on adiposity and insulin resistance (both are precursors to T2D) in human and animal models, which have recently been confirmed in several large prospective studies of multiethnic populations that comprehensively assess these endogenous sex hormones and clarify their bi…”
BackgroundResultPolymorphisms in the SHBG Gene Influence Serum SHBG Levels in Women with Polycystic Ovary Syndrome
Wickham, E. P., Ewens, K. G., Legro, R. S., Dunaif, A., Nestler, J. E., & Strauss, J. F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1842 · Cited by 64
Glucose intolerance states in women with the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2013) · Journal of Endocrinological Investigation · doi:10.1007/bf03346757 · Cited by 67
“Interestingly, in the previous study on the impact of rs1799941 SNP of SHBG, no association was observed with insulin levels or various measures of insulin resistance or insulin secretion (61).”
Londen, G. J. V., Perera, S., Vujevich, K. T., Rastogi, P., Lembersky, B. C., Brufsky, A., Vogel, V. G., & Greenspan, S. L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1223-2 · Cited by 71
“Similarly, we are only starting to understand that SHBG per se can play an active role as well: decreased levels of SHBG increase risk of diabetes mellitus II and vice versa [22, 23].”
Mather, K. J., Kim, C., Christophi, C. A., Aroda, V. R., Knowler, W. C., Edelstein, S. E., Florez, J. C., Labrie, F., Kahn, S. E., Goldberg, R. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2328 · Cited by 61
“We evaluated three SNPs at the SHBG locus (rs6259 (15); rs6257 (16); and rs1799941 (17)) that have been previously associated with SHBG levels and with diabetes outcomes (7, 9).”
MethodPinkney, J. H., Streeter, A., Hosking, J., Mohammod, M., Jeffery, A., & Wilkin, T. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3902 · Cited by 67
“The mechanisms responsible for declining SHBG levels are uncertain, although SHBG is influenced by genotype (3, 4), early”
BackgroundShin, J. Y., Kim, S., Lee, M. Y., Kim, H. S., Ye, B. I., Shin, Y. G., Baik, S. K., & Chung, C. H. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.07.029 · Cited by 63
“Two studies, using Mendelian randomization analyses, suggested that circulating SHBG may play a causal role in the development of type 2 diabetes [12,16].”
BackgroundCausal associations between cardiorespiratory fitness and type 2 diabetes
Cai, L., Gonzales, T. I., Wheeler, E., Kerrison, N. D., Day, F. R., Langenberg, C., Perry, J. R. B., Brage, S., & Wareham, N. J. (2023) · Nature Communications · doi:10.1038/s41467-023-38234-w · Cited by 61
Self-citationHaring, R., Teumer, A., Völker, U., Dörr, M., Nauck, M., Biffar, R., Völzke, H., Baumeister, S. E., & Wallaschofski, H. (2013) · Andrology · doi:10.1111/j.2047-2927.2012.00002.x · Cited by 55
“First, the SHBG SNP rs12150660, presently applied as a genetic instrument, was previously related to circulating sex hormone-binding globulin (SHBG) concentrations (Ding et al., 2009; Perry et al., 2010).”
BackgroundBurgdorf, K. S., Grarup, N., Justesen, J. M., Harder, M. N., Witte, D. R., Jørgensen, T., Sandbæk, A., Lauritzen, T., Madsbad, S., Hansen, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015813 · Cited by 54
Self-citationBrand, J. S., Wareham, N. J., Dowsett, M., Folkerd, E., van der Schouw, Y. T., Luben, R. N., & Khaw, K.-T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03951.x · Cited by 55
Self-citationAdiponectin Trajectories Before Type 2 Diabetes Diagnosis
Tabák, A. G., Carstensen, M., Witte, D. R., Brunner, E. J., Shipley, M. J., Jokela, M., Roden, M., Kivimäki, M., & Herder, C. (2012) · Diabetes Care · doi:10.2337/dc11-2263 · Cited by 55
Self-citationMartinez-Garcia, M. A., Gambineri, A., Alpanes, M., Sanchon, R., Pasquali, R., & Escobar-Morreale, H. F. (2012) · Human Reproduction · doi:10.1093/humrep/des335 · Cited by 50
Definition, Prevalence, and Risk Factors of Low Sex Hormone-Binding Globulin in US Adults
Wang, Y. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab416 · Cited by 50
“Genetic studies, which are less likely to be confounded, biased, or influenced by disease processes, showed that SHBG-raising alleles were associated with a reduced risk of type 2 diabetes (30), suggesting that SHBG may be involved in the etiology of diabetes.”
Background(2013) · PubMed · doi:10.3275/9023 · Cited by 48
Rooney, M. R., Chen, J., Echouffo-Tcheugui, J. B., Walker, K. A., Schlosser, P., Surapaneni, A., Tang, O., Chen, J., Ballantyne, C. M., Boerwinkle, E., et al. (2023) · Diabetes Care · doi:10.2337/dc22-1830 · Cited by 64
Role of hepatokines in non-alcoholic fatty liver disease
Ke, Y., Xu, C., Lin, J., & Li, Y. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0029 · Cited by 46
“However, the level of circulating SHBG has also been shown to be associated with glucose metabolism, quantity of the adipose tissue and metabolism disorders.[57,58] The SHBG level in the liver and peripheral was significantly lower in patients with hepatic steatosis, where serum SHBG was found to be negatively associa…”
BackgroundJaspers, L., Dhana, K., Muka, T., Meun, C., Jong, J. C. K., Hofman, A., Laven, J. S. E., Franco, O. H., & Kavousi, M. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1435 · Cited by 46
Goto, A., Morita, A., Goto, M., Sasaki, S., Miyachi, M., Aiba, N., Terauchi, Y., Noda, M., Watanabe, S., & the Saku Cohort Study Group (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-130 · Cited by 47
Bann, D., Wu, F. C. W., Keevil, B. G., Lashen, H., Adams, J. E., Hardy, R., Terrera, G. M., Kuh, D. J., Ben‐Shlomo, Y., & Ong, K. K. (2015) · Obesity · doi:10.1002/oby.21092 · Cited by 40
“In support of this, SHBG genetic variations conferring higher SHBG concentrations have been associated with lower risk of type-2 diabetes (34), which is thought to be partly determined by fat mass levels.”
BackgroundInsulin Resistance Associated Genes and miRNAs
Honardoost, M., Sarookhani, M. R., Arefian, E., & Soleimani, M. (2014) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-014-1014-z · Cited by 43
Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications
Kumar, M., Dutta, D., Anne, B., Shivaprasad, Sinha, A., Ray, S., & Chowdhury, S. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s50777 · Cited by 47
“Similar findings were also reported by Perry et al.22 Lakshman et al19 showed that even after adjusting for free testosterone or total testosterone, SHBG was a strong predictor of incident diabetes.”
ResultZhang, B., Jin, Z., Sun, L., Yang, Z., Jiang, J.-X., Feng, C., & Wang, Y. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.07.003 · Cited by 42
Chen, B. H., Brennan, K., Goto, A., Song, Y., Aziz, N., You, N. Y., Wellons, M., Manson, J. E., White, D. L., Butch, A. W., et al. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2012.193086 · Cited by 43
Impact of sex hormone-binding globulin on the human phenome
Arathimos, R., Millard, L. A. C., Bell, J. A., Relton, C. L., & Suderman, M. J. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddz269 · Cited by 40
“454) in the MR-pheWAS, despite prior observational and genetic evidence of a protective effect (8, 9, 36, 37).”
BackgroundThe Pathological Links between Adiposity and the Carpal Tunnel Syndrome
Oțelea, M. R., Nartea, R., Popescu, F. G., Covaleov, A., Mitoiu, B. I., & Nica, A. S. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44060181 · Cited by 45
“Low SHGB was found in central obesity and T2DM in epidemiological and genetic research [153,154].”
BackgroundSex Hormone-Binding Globulin and Risk of Coronary Heart Disease in Men and Women
Li, J., Zheng, L., Chan, K. H. K., Zou, X., Zhang, J., Liu, J., Zhong, Q.-W., Madsen, T. E., Wu, W., Manson, J. E., et al. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvac209 · Cited by 45
Zhao, J. V., & Schooling, C. M. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020050659 · Cited by 38
Davis, S. R., Robinson, P. J., Moufarege, A., & Bell, R. J. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04301.x · Cited by 38
Metabolic insights from extreme human insulin resistance phenotypes
Stears, A. J., O’Rahilly, S., Semple, R. K., & Savage, D. B. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.09.003 · Cited by 44
Taylor, S. R., Meadowcraft, L., & Williamson, B. (2015) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1623 · Cited by 35
“Furthermore, lower SHBG levels are associated with an increased risk of developing T2DM, whereas higher levels seem to be protective.(21) With regard to insulin resistance, when insulin receptors in mice were deleted, insulin resistance occurred, and LH concentrations were reduced by 60–90%, resulting in decreased tes…”
BackgroundAssociations between polymorphisms in sex steroid related genes and autistic-like traits
Zettergren, A., Jönsson, L., Johansson, D., Melke, J., Lundström, S., Anckarsäter, H. S., Lichtenstein, P., & Westberg, L. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.06.004 · Cited by 38
Circulating testosterone and SHBG concentrations are heritable in women: the Framingham Heart Study
Coviello, A. D., Zhuang, W. V., Lunetta, K. L., Bhasin, S., Ulloor, J., Zhang, A., Karasik, D., Kiel, D. P., Vasan, R. S., & Murabito, J. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0050 · Cited by 33
Dimou, N. L., Mori, N., Harlid, S., Harbs, J., Martin, R. M., Smith-Byrne, K., Papadimitriou, N., Bishop, D. T., Casey, G., Colorado-Yohar, S. M., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1690 · Cited by 35
“Variant rs1799941 is common, while rs6258 is rare and alters SHBG’s binding affinity for testosterone (33,34).”
BackgroundChen, C., Smothers, J., Lange, A., Nestler, J. E., Strauss, J. F., & Wickham, E. P. (2010) · PubMed · Cited by 40
Association Between Statin Use and Sex Hormone in the Multi-Ethnic Study of Atherosclerosis Cohort
Oluleye, O. W., Kronmal, R. A., Folsom, A. R., Vaidya, D. M., Ouyang, P., Duprez, D. A., Dobs, A. S., Yarmohammadi, H., & Konety, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00530 · Cited by 32
Hsu, B., Cumming, R. G., Naganathan, V., Blyth, F., Couteur, D. G. L., Seibel, M. J., Waite, L. M., & Handelsman, D. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2464 · Cited by 30
Song, Y., Huang, Y.-T., Song, Y., Hevener, A. L., Ryckman, K. K., Qi, L., LeBlanc, E. S., Kazlauskaite, R., Brennan, K. M., & Liu, S. (2015) · Diabetologia · doi:10.1007/s00125-014-3479-2 · Cited by 30
“SHBG may be yet another important hepatokine [38] in the regulation of glucose homeostasis [13, 39].”
BackgroundThe hepatic lipidome and HNF4α and SHBG expression in human liver
Winters, S. J., Scoggins, C. R., Appiah, D., & Ghooray, D. T. (2020) · Endocrine Connections · doi:10.1530/ec-20-0401 · Cited by 28
Liu, C., Huang, S., Cheng, K., Hsieh, T., Huang, C., Wang, C., Yeh, H., Tsai, C.-C., Bao, B., Wu, W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03078-0 · Cited by 31
Svartberg, J., Schirmer, H., Wilsgaard, T., Mathiesen, E. B., Njølstad, I., Løchen, M.-L., & Jorde, R. (2014) · Andrology · doi:10.1111/j.2047-2927.2013.00174.x · Cited by 32
“In a recent publication including 27 657 T2DM patients and 58 481 controls from 15 studies, the minor homozygote allele of rs1799941 associated with higher SHBG levels was associated with reduced risk of T2DM (Perry et al., 2010).”
BackgroundIntroduction to Personalized Medicine in Diabetes Mellitus
Glauber, H. S., Rishe, N. D., & Karnieli, E. (2014) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10136 · Cited by 31
Lee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
“-Mice with adipocyte-aromatase overexpression have improved insulin sensitivity and reduced in fl ammation (97).”
Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations
Jaschke, N., Wang, A., Hofbauer, L. C., Rauner, M., & Rachner, T. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101301 · Cited by 30
Longitudinal associations between sex hormone-binding globulin and insulin resistance
Ottarsdottir, K., Hellgren, M. I., Bock, D., Nilsson, A. G., & Daka, B. (2020) · Endocrine Connections · doi:10.1530/ec-20-0141 · Cited by 26
“…studies on polymorphism of the SHBG gene have showed that genetic variants associated with low levels of SHBG are also associated with higher risk for developing type 2 diabetes, suggesting that SHBG might be involved per se in the pathophysiology of diabetes and insulin resistance (4, 31).”
Maggio, M., Cattabiani, C., Lauretani, F., Artoni, A., Bandinelli, S., Schiavi, G., Vignali, A., Volpi, R., Ceresini, G., Lippi, G., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.09.014 · Cited by 24
Self-citationBuilding Genetic Scores to Predict Risk of Complex Diseases in Humans: Is It Possible?
Liu, S., & Song, Y. (2010) · Diabetes · doi:10.2337/db10-1081 · Cited by 30
“With a better understanding of pathogenesis, however, integrating genetic variants with their biochemical phenotypes, as recently demonstrated in a study of sex-hormone–binding globulin and type 2 diabetes risk, should be a viable strategy to provide molecular insights and improve disease prediction (22,27).”
BackgroundNew Insights in the Diagnostic Potential of Sex Hormone-Binding Globulin (SHBG)—Clinical Approach
Szybiak, W., Cyna, W., & Łącka, K. (2025) · Biomedicines · doi:10.3390/biomedicines13051207 · Cited by 25
“On the contrary, the rs6257 SHBG variant was associated with increased risk of DM2 due to the effect of lowering the concentration of SHBG [72].”
InfluentialWan, Q., Xie, Y., Zhou, Y., & Shen, X. (2020) · Andrologia · doi:10.1111/and.13893 · Cited by 27
Simons, P. I. H. G., Valkenburg, O., Bons, J. A. P., Stehouwer, C. D. A., & Brouwers, M. C. G. J. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.267 · Cited by 30
Linder, K., Wagner, R. J., Hatziagelaki, E. E., Ketterer, C., Heni, M., Machicao, F. E., Stefan, N., Staiger, H., Häring, H., & Fritsche, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038224 · Cited by 24
“For example, sexual hormone binding globulin (SHBG) levels were negatively associated with diabetes [34,35] and diabetes related traits [36], and studies utilizing mendelian randomization with the SHBG gene provide evidence for a causal link [37].”
BackgroundZhang, T., Du, T., Li, W., Yang, S., & Liang, W. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0030 · Cited by 24
Li, M.-Y., Rawal, S., Hinkle, S. N., Zhu, Y.-Y., Ayele, F. T., Tsai, M. Y., Liu, S., & Zhang, C. (2020) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000037 · Cited by 22
Metadata
- Authors
- Perry, J. R. B., Weedon, M. N., Langenberg, C., Jackson, A. U., Lyssenko, V., Sparsø, T., Thorleifsson, G., Grallert, H., Ferrucci, L., Maggio, M., Paolisso, G., Walker, M., Palmer, C. N. A., Payne, F., Young, E., Herder, C., Narisu, N., Morken, M. A., Bonnycastle, L. L., Owen, K. R., Shields, B., Knight, B., Bennett, A., Groves, C. J., Ruokonen, A., Jarvelin, M. R., Pearson, E., Pascoe, L., Ferrannini, E., Bornstein, S. R., Stringham, H. M., Scott, L. J., Kuusisto, J., Nilsson, P., Neptin, M., Gjesing, A. P., Pisinger, C., Lauritzen, T., Sandbaek, A., Sampson, M., Zeggini, M., Lindgren, C. M., Steinthorsdottir, V., Thorsteinsdottir, U., Hansen, T., Schwarz, P., Illig, T., Laakso, M., Stefansson, K., Morris, A. D., Groop, L., Pedersen, O., Boehnke, M., Barroso, I., Wareham, N. J., Hattersley, A. T., McCarthy, M. I., & Frayling, T. M.
- Affiliations
- University of Exeter (GB)
- Addenbrooke's Hospital (GB)
- University of Michigan (US)
- Lund University (SE)
- Helmholtz Munich (DE)
- National Institutes of Health (US)
- University of Parma (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Newcastle University (GB)
- University of Dundee (GB)
- Wellcome Sanger Institute (GB)
- Deutsches Diabetes-Zentrum e.V. (DE)
- National Human Genome Research Institute (US)
- Churchill Hospital (GB)
- University of Pisa (IT)
- Technische Universität Dresden (DE)
- Kuopio University Hospital (FI)
- Glostrup Hospital (DK)
- Norfolk and Norwich University Hospital (GB)
- Centre for Human Genetics (GB)
- University of Southern Denmark (DK)
- University of Copenhagen (DK)
- Corresponding author
- Frayling, Timothy M.
- ORCID
- Perry, John R.B.
- Weedon, Michael N.
- Langenberg, Claudia
- Jackson, Anne U.
- Lyssenko, Valeriya
- Grallert, Harald
- Ferrucci, Luigi
- Maggio, Marcello
- Paolisso, Giuseppe
- Walker, Mark
- Payne, Felicity
- Herder, Christian
- Narisu, Narisu
- Bonnycastle, Lori L.
- Owen, Katharine R.
- Shields, Beverley
- Bennett, Amanda
- Pearson, Ewan
- Pascoe, Laura
- Ferrannini, Ele
- Bornstein, Stefan R.
- Stringham, Heather M.
- Scott, Laura J.
- Nilsson, Peter
- Neptin, Malin
- Gjesing, Anette P.
- Pisinger, Charlotta
- Lauritzen, Torsten
- Sampson, Mike
- Lindgren, Cecilia M.
- Hansen, Torben
- Schwarz, Peter
- Laakso, Markku
- Morris, Andrew D.
- Groop, Leif
- Pedersen, Oluf
- Boehnke, Michael
- Barroso, Inês
- Wareham, Nicholas J.
- Hattersley, Andrew T.
- McCarthy, Mark I.
- Frayling, Timothy M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-18
- Volume
- 19
- Issue
- 3
- Pages
- 535-544
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2798726
- OpenAlex
- W2139109527
- Cited by
- 217
- References
- 40
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 17 · 2023: 10 · 2022: 9 · 2021: 19 · 2020: 15 · 2019: 10 · 2018: 7 · 2017: 13 · 2016: 8 · 2015: 13 · 2014: 13 · 2013: 14 · 2012: 25
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Human Molecular Genetics (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, cc-by-nc)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Site cant be reached (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- American Diabetes Association
- Pfizer
- AstraZeneca (QLG1-CT-2001-01252)
- Hjerteforeningen
- Aarhus Universitet
- Sundhed og Sygdom, Det Frie Forskningsråd
- Wellcome Trust (083270, GR072960, 077016, 083270/Z/07/Z, 077016/Z/05/Z, 090532, 518153, 076113)
- National Institute for Health and Care Research (DHCS/07/07/008)
- Diabetes UK
- European Commission (QLG1-CT-2001-01252)
- Academy of Finland (124243)
- Bundesministerium für Bildung und Forschung
- Aarhus Universitets Forskningsfond
- Technische Universität Dresden
- Bundesministerium für Gesundheit
- Lundbeckfonden
- Novo Nordisk
- Augustinus Fonden
- Novo Nordisk Fonden
- Servier
- H. Lundbeck A/S
- Diabetesforeningen
- National Institutes of Health (DK062370)
- Medical Research Council (G0601261)
- Münchner Zentrum für Gesundheitswissenschaften
- National Institute on Aging (R01 AG 24233-01, R01 AG24233-0, R01AG24233, R01AG024233)
- National Institute on Drug Abuse (U54DA021519)
- National Human Genome Research Institute (Z01HG000024, HG000024)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-072193, R01DK072193, U01DK062370, R01DK069922, R56DK062370, DK069922, DK-062370, R01DK062370)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- sex hormone-binding globulin, type 2 diabetes, SHBG gene, Mendelian randomization, causal inference, sex hormones, insulin secretion, insulin resistance, diabetes risk
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Female, Humans, Male, Middle Aged, Risk Factors, Sex Hormone-Binding Globulin, Gonadal Steroid Hormones, Case-Control Studies, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.